Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime?
Ann Oncol. 2018 Mar 1;29(3):532-534.
doi: 10.1093/annonc/mdy043.
1 Cancer Genomics Lab, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
2 Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; CIBERONC, Barcelona, Spain; Universitat Autònoma de Barcelona (UAM), Barcelona, Spain.
3 CIBERONC, Barcelona, Spain; Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain; Oncobell, IDIBELL, Barcelona, Spain; Universitat de Barcelona (UB), L'Hospitalet, Barcelona, Spain. Electronic address: ramonsalazar@iconcologia.net.